CellWell record HH-4381
Beneficial changes in total cholesterol, LDL-C, biomarkers of intestinal inflammation, and vitamin E status in adults with metabolic syndrome consuming almonds as snack foods: a randomized controlled clinical trial.
Beaver LM; Leonard SW; Uesugi SL; Wong CP; Lytle LM; Vasudevan A; Papenhausen EM; Jupudi Y; Bella D; Bobe G; Traber MG; Ho E
Nutrition research (New York, N.Y.) ยท 2025
In plain language
A randomized controlled trial on Vitamin E found that total body weight, caloric intake, and markers of carbohydrate metabolism (glucose, insulin), systemic inflammation (plasma interleukin-6, C-reactive protein, lipopolysaccharide-binding protein, CD14), and oxidative damage (malondialdehyde) were not altered by almond consumption.
- Evidence
- Emerging
- Design
- Randomized controlled trial
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-4381
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.